Twelve scientists from St. Jude Children’s Research Hospital are among the investigators named to the 2023 list of Highly Cited Researchers. The annual list selects individuals who have demonstrated significant and broad influence in their research fields. Each researcher on the list has authored multiple scientific papers that rank in the top 1% by citations for their fields in the year the work was published.
Citations refer to how often a published research paper is included as a reference by other investigators in their work, which is a measure of that research paper’s reach and influence. Of the world’s population of scientists, Highly Cited Researchers represent 1 in 1,000. The list is compiled by the Institute for Scientific Information at Clarivate, a London-based firm that publishes the list.
“While no single metric can convey the full picture, it is gratifying to be considered a highly cited researcher because it means that our hard work has an impact,” said Tanja Mittag, Ph.D., Structural Biology. “Many of our most highly cited papers are the result of collaborative work, with scientists at St. Jude and other institutions, illustrating the importance of trying to push the boundaries of interdisciplinary problems.”
The 2023 list includes St. Jude scientists from eight departments and research centers.
“It is deeply rewarding to be named to this list because it reflects how our work provides lasting value to other leading scientists,” said Brian Abraham, Ph.D., Computational Biology. “It’s a reminder of how we are all pushing each other to make discoveries and expand our knowledge.”
St. Jude scientists on the 2023 Highly Cited Researchers list:
- Brian Abraham, Ph.D., Computational Biology (Molecular Biology and Genetics)
- Kelly Caudle, Pharm.D., Ph.D., Pharmacy and Pharmaceutical Sciences (Pharmacology and Toxicology)
- Kristine Crews, Pharm.D., Pharmacy and Pharmaceutical Sciences (Pharmacology and Toxicology)
- Hongbo Chi, Ph.D., Immunology (Immunology)
- Douglas Green, Ph.D., Immunology (Immunology, Molecular Biology and Genetics)
- Thirumala-Devi Kanneganti, Ph.D., Immunology vice-chair (Immunology)
- Tanja Mittag, Ph.D., Structural Biology (Cross-Field)
- Mary Relling, Pharm.D., Pharmacy and Pharmaceutical Sciences, emeritus (Pharmacology and Toxicology)
- J. Paul Taylor, M.D., Ph.D., Executive Vice President, Scientific Director and Cell & Molecular Biology chair (Cross Field)
- Paul Thomas, Ph.D., Host-Microbe Interactions and Immunology (Cross-Field)
- Shengdar Tsai, Ph.D., Hematology (Biology and Biochemistry)
- Peter Vogel, D.V.M., Ph.D., Pathology (Immunology)
The 2023 list includes 6,849 researchers from 67 countries and regions, 37.5% of which hail from institutions in the United States.
“Often, publishing our work feels like the culmination of a long journey, but we also hope it is just the start of that work becoming useful to the scientific community,” said Thomas. “One of the missions of St. Jude is to share our findings widely and help other scientists advance their studies using the discoveries we have made. Being acknowledged as one of the most highly cited researchers is a great honor and motivation to keep producing work that moves the field forward and contributes to the progress of science at large.”
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.